EUVIMEDEUVIMED entdecken
Crossref

Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study.

The Internet Journal of Asthma, Allergy and Immunology · 2011

DOI: 10.5580/22b1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Internet Journal of Asthma, Allergy and Immunology, 2011.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2011). Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/22b1

Vancouver

Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. 2011. doi:10.5580/22b1

BibTeX
@article{euvimed2011,
  title = {Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study},
  journal = {The Internet Journal of Asthma, Allergy and Immunology},
  year = {2011},
  doi = {10.5580/22b1}
}
Kostenlos starten →